Smallwood et al. demonstrated that autologous patient CD4+ T cells internalized chronic lymphocytic leukemia (CLL)-TEX-containing miR-363 that targets the immunomodulatory molecule CD69. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.